RGCC Lab Testing

Oncotrace

• Purpose: Determines the origin of detected CTCs and tracks treatment response.
• Sample: 7-10 ml blood
• Use for: Identifying tumor origin, monitoring recurrence and monitoring therapeutic response to treatments.

Oncotrail

• Purpose: Monitors CTC levels for specific cancer types (prostate, breast, colon, lung).
• Sample: 10 ml blood
• It is used for disease monitoring after tumor site identification and to determine if the primary site is known before testing.

 Onconomics Plus

• Purpose: Determines the best pharmaceutical and natural treatment options.
• Sample: 15-25 ml blood
• It is used for combined assessment of medical and natural treatments and used to create a year-long plan.

 Immuneframe

• Purpose: Evaluate immune function and response to cancer.
• Sample: 15-25 ml blood
• It is used for immune system analysis, support strategies, and determination of whether the person is a candidate for vaccine therapy.

Note: Blood samples should be collected in RGCC-provided tubes, and results may take several weeks, depending on the test.

Array Comparative Hybridization (aCGH)

• Purpose: Identifies the primary tumor origin through DNA analysis of circulating tumor cells (CTCs).
  • Used if the cancer is of unknown origin
• Sample: Blood
• Turnaround: 3-4 weeks
• Use for: All cancer types

Imaging

PET Scan (Positron Emission Tomography): Primarily used to detect metabolic activity in tissues and organs.

• Commonly used for:
• Cancer detection and staging
• Monitoring cancer treatment response
• Neurological conditions (e.g., Alzheimer’s disease)
• Cardiovascular diseases (e.g., evaluating heart function)

Whole-Body MRI: Provides detailed anatomical images of soft tissues, organs, and bones without radiation.

• Commonly used for:

Detecting structural abnormalities

• Evaluating musculoskeletal and neurological conditions
• Screening for tumors or other abnormalities
• Monitoring chronic diseases like multiple sclerosis or arthritis

*PET scan is the preferred test for metastasis and is required before SOT infusion is approved.